In the CD56+ subset, a statistically significant increase in the proportion of KIR2DL2/DL3+ T cells was detected in the ICU patients, MS patients, and convalescents compared to HD (Figure 5a). The gene discussed is NCAM1; the disease is myeloid sarcoma.